Analyst Meeting 20210301

21
TER BEKE 2020 RESULTS ANALYST MEETING MARCH 1, 2021

Transcript of Analyst Meeting 20210301

Page 1: Analyst Meeting 20210301

TER BEKE 2020 RESULTS

ANALYST MEETING

MARCH 1, 2021

Page 2: Analyst Meeting 20210301

TER BEKE CONSOLIDATED

Analyst Meeting2

◆Top line overall -1,5% due to Covid predominantly. ◆H1 challenges (Pork pricing / efficiency NL post recall / Covid) turned around in H2

◆ Raw material pricing normalised◆ Restructuring impact visible, especially in NL (Project unity: merger Offerman – Ter Beke legacy) ◆ Back on track and ZBB measures contributed

◆Solid net debt performance: 25Mio cash generation, net debt at <100Mio, Leverage 2,2x U-EBITDA

HEADLINES

March 1, 2021

-20 000

-10 000

0

10 000

20 000

30 000

40 000

06/2

010

12/2

010

12/2

010

06/2

011

12/2

011

06/2

012

12/2

012

06/2

013

12/2

013

06/2

014

12/2

014

06/2

015

12/2

015

06/2

016

12/2

016

06/2

017

12/2

017

06/2

018

12/2

018

06/2

019

12/2

019

06/2

020

12/2

020

LONG TERM EVOLUTION

EBITDA EBIT EAT

Page 3: Analyst Meeting 20210301

TER BEKE CONSOLIDATED

Analyst Meeting3

◆Purchase Prices improved vs H1◆ Impact restructuring in H1: Fixed cost reduction & non-repeat of restructuring expenses◆Operational improvements –KPI’s back to normal level ◆Covid impact 2nd lockdown less severe vs. lockdown 1

WHAT CHANGED IN H2 vs H1?

March 1, 2021

EUR’000 H1 2020 H2 2020

U-EBITDA 12,575 33,136

EBITDA 6,176 30,964

U-EBIT -2,324 17,794

EBIT -9,971 14,810

EAT -9,811 7,348

Page 4: Analyst Meeting 20210301

EVOLUTION 2020

Analyst Meeting 4

(U)-EBITDA Evolution (in 000 EUR)

EAT Evolution (in 000 EUR)(U)-EBIT Evolution (in 000 EUR)

Net Sales Evolution (in 000 EUR)

March 1, 2021

0100000200000300000400000

Net Sales

- 10 000 20 000 30 000 40 000

U-EBITDA

-5 000 -

5 000 10 000 15 000 20 000

U-EBIT

-15 000-10 000

-5 0000

5 00010 00015 000

EAT

Page 5: Analyst Meeting 20210301

Analyst Meeting 5

NON UNDERLYING ITEMS (IN 000 EUR)

◆ Restructuring ‘back on track’ in BE /NL / UK mainly

◆ Integration Dutch businesses –project Unity.

◆ Releases◆ Simplification structure ◆ 1 management team◆ 2 Mio non-cash related to

accelerated depreciation building & machines Aalsmeer

◆ Covid-19 expenses ◆ Protection equipment◆ Cleaning expenses etc. ◆ Mainly related to H1

HEADLINES

March 1, 2021

31/12/2020 31/12/2019

Severance payment (incl social costs) 3 942 3 125Project 'unity Netherlands' 4 361Claim vs sellers Stefano Toselli -438Costs of acquisitions 125Recall 379 7 914Covid-19 expenses 1 886Others 63Impairment on building Aalsmeer 500

non-underlying items (in EBIT) 10 631 11 226

Page 6: Analyst Meeting 20210301

NET DEBT & EQUITY

Analyst Meeting6

◆Good cash generation thanks to solid operating cashflow & working capital improvement◆Despite high Capex (as expected) due to investment in expansion project in Opole, Poland◆Equity impacted by OCI Fx impact and results - to bounce back in 2021◆Leverage 2,2x U-EBITDA, liquidity headroom 117 Mio EUR per 31/12/2020

HEADLINES

March 1, 2021

90 00095 000

100 000105 000110 000115 000120 000125 000130 000

2 017 2 018 2 019 2 020

NET DEBT

112 000

114 000

116 000

118 000

120 000

122 000

124 000

126 000

2 017 2 018 2 019 2 020

EQUITY

Page 7: Analyst Meeting 20210301

LOOKING FORWARD

Analyst Meeting7

◆ Proposed scrip dividend (NL: keuzedividend) of 4€. Uninterrupted dividend since start listing. ◆ Ebitda 2021 to exceed 2020 (except unforeseen matters). ◆ CEO departure 30/6/2021 – recruitment underway◆ Probable disposal of Captive company in Luxembourg after strategic review:

◆ External cover available ◆ Increasing compliance expenses ◆ One-time negative impact on EAT and Cash estimated between 4 and 5 million EUR

March 1, 2021

Page 8: Analyst Meeting 20210301

PROCESSEDMEATS

MARCH 1, 2021

Page 9: Analyst Meeting 20210301

TER BEKE PROCESSED MEATS DIVISION

Analyst Meeting 9

◆ Nr.1 in processed meats in the Benelux ◆ Largest slicer and packager ◆ Able to cover 65% of product range in production logs◆ Private Label Retail focus ◆ Branded OTC & wholesale offering

◆Difficult market◆ Price pressure in market with overcapacity◆ Increasing competition of alternatives

◆ 2020 events◆ Positive effects of

◆ Market volume increases in retail due to increased consumption & reduced slicing on shop floor (due to quality & regulatory requirements) Net sales +2,2%

◆ Restructuring & integration of the business in the Netherlands◆ Restructuring in Belgian units as part of Back on track

programme◆ ZBB programme

◆ However countered by◆ High one off expenses related to the restructurings in H1◆ High raw material prices in H1◆ Aftermath of Recall & transfer of volumes Aalsmeer in H1

HEADLINES Sales Evolution (in 000 EUR)

U-EBITDA and U-EBIT evolution (in 000 EUR)

March 1, 2021

300000

350000

400000

450000

500000

2017 2018 2019 2020

-5000

0

5000

10000

15000

20000

2017 2018 2019 2020

U-EBITDA U-EBIT

Page 10: Analyst Meeting 20210301

READY MEALS

MARCH 1, 2021

Page 11: Analyst Meeting 20210301

TER BEKE READY MEALS DIVISION

Analyst Meeting 11

◆ Nr.1 chilled Italian pasta meals in Europe◆ Geographic expansion of sales continues◆ Pan-European supply from 4 lasagne & pasta meals

factories & 1 frozen world cuisine factory◆ Strong position in retail, KK fine foods focus on both

foodservice & retail

◆Difficult year due to Covid◆ KK Fine Foods sales drop significant due to covid◆ 1st Lockdown impacting lasagne retail sales

◆ 2020 events◆ Positive effects of

◆ Solid operational performance in difficult circumstances◆ Come a casa positive feedback on rebranding◆ Expansion programme Opole Poland (on track & on budget)◆ Retail growth at KK Fine Foods

◆ However countered by◆ High raw material prices in H1◆ Covid impact on top-line, triggering net sales decrease by -7%

(entirely attributable to KK Foodservice decline)

HEADLINES Sales Evolution (in 000 EUR)

U-EBITDA and U-EBIT evolution (in 000 EUR)

March 1, 2021

050000

100000150000200000250000300000350000

2017 2018 2019 2020

SALES

0

10000

20000

30000

40000

2017 2018 2019 2020

U-EBITDA U-EBIT

Page 12: Analyst Meeting 20210301

FINANCIALS2020

MARCH 1, 2021

Page 13: Analyst Meeting 20210301

CONSOLIDATED INCOME STATEMENT 2020

13

HEADLINES

◆ Sales decrease by 1,5% due to Covid◆ Volatile raw material prices ◆ Overhead expense reduction following ‘Back on

track’ programme – however with high one off restructuring expense due to staff releases

◆ Accelerated depreciation machines & building Aalsmeer.

◆ Higher Financial expenses due to 1,2 Mio EUR impact on EUR denominated loan towards Pasta Food Company in Poland.

◆ Taxes 2019 positive due to:◆ Deferred tax asset recognized on polish tax

subsidies due to the positive profit evolution in Pasta Food Company

◆ Effective tax rate 2020 influenced by ◆ Effect of different tax rate in other countries◆ Non-recognized DTA impact◆ Disallowed expenses

Analyst Meeting March 1, 2021

Page 14: Analyst Meeting 20210301

Consolidated Balance Sheet 2020

14

HEADLINES

◆ Decrease in tangible and intangible fixed assets of 1,7 mainly due to accelerated depreciation of machinery & building in Aalsmeer (2 Mio EUR)

◆ Inventories slightly lower due to Covid (Foodservice products)

◆ Significant improvement on working capital◆ Cash to be considered together with financial

debt. Net debt improvement by almost 25 Mio.

Analyst Meeting March 1, 2021

Page 15: Analyst Meeting 20210301

Consolidated Balance Sheet 2020

15

HEADLINES

◆ Lower indebtedness after focus on working capital

◆ Provision purchase remaining shares in KK fine Foods relatively stable due to long-term expected recovery. After year-end, 1% was purchased in January 2021. (9% remaining after transaction)

◆ Accounts payable improved versus 2019

Analyst Meeting March 1, 2021

Page 16: Analyst Meeting 20210301

Cashflow Statement

16

HEADLINES

◆ Net cash flow from operating activities improved by 16,7 Mio EUR mainly due to a working capital improvement.

Analyst Meeting

Page 17: Analyst Meeting 20210301

Cashflow Statement

17

HEADLINES

◆ Increased investment activity as expected –predominantly linked to capacity expansion in Opole, Poland factory.

◆ Various other energy efficiency & qualityenhancing investments done during 2020.

◆ RCF remains main source of external financing. ◆ Capital increase linked to scrip dividend in 2020.

Analyst Meeting March 1, 2021

Page 18: Analyst Meeting 20210301

Cashflow Statement

18Analyst Meeting March 1, 2021

Page 19: Analyst Meeting 20210301

Evolution external segment reporting

Analyst Meeting 19March 1, 2021

2020 FY 2019 FY

Page 20: Analyst Meeting 20210301

Segmentinformatie

Analyst Meeting 20March 1, 2021

Page 21: Analyst Meeting 20210301

FINANCIALS2020

MARCH 1, 2021

QUESTIONS

?

MARCH 1, 2021